Subscribe for the newsletter
Mobile Navigation
Subscribe for the Newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Takara Bio
Sort By
Newest First
Sign in
1 / 1
1 / 1
Immunotherapy
Takara Bio submits Drug Master File to US FDA for RetroNectin® GMP grade (liquid format)
Takara Bio Inc
PR-M04-19-NI-048
Apr 15, 2019
